Yasin Keshvargar

We advised the underwriters on the public equity offering

We advised the underwriters on the IPO of ADSs

Davis Polk advised (i) the joint lead arrangers and joint bookrunners and (ii) the administrative agent, in connection with a $550 million senior secured term loan facility and a $400…

Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Solid Biosciences Inc. of $90 million of common stock. Solid Biosciences Inc…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $307 million public offering of 4,150,000 shares of common stock…

Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,400,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14,375,000 shares of common stock of Atea Pharmaceuticals, Inc.,…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million initial public offering by Biodesix, Inc. The common stock is listed on…

Davis Polk advised the representative of the initial purchasers in connection with the debut Rule 144A/Regulation S offering by LD Holdings Group LLC of $500 million aggregate principal…